Akari Therapeutics awards interim CFO Kameel Farag 2,873 restricted stock units
AKTX•Akari Therapeutics interim CFO Kameel D. Farag received 2,873 American Depositary Shares representing ordinary shares on November 17, 2026. His direct holdings totaled 26,182 American Depositary Shares after the transactions.
1. Share award
Akari Therapeutics interim CFO Kameel D. Farag received 2,873 American Depositary Shares representing ordinary shares on November 17, 2026. His direct holdings totaled 26,182 American Depositary Shares following the transactions.




